Imodium (Loperamide Hydrochloride)

Loperamide hydrochloride activates peripheral μ‑opioid receptors in the intestinal wall, which slows peristalsis, increases the time for water absorption, and reduces intestinal secretions. This results in firmer stools and fewer bowel movements.

The appropriate dose of Imodium is determined by a healthcare professional based on the patient’s age, weight, and severity of symptoms. Patients should follow the prescriber’s instructions or the label guidance for over‑the‑counter use.

Safety data for loperamide in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Imodium to weigh potential benefits against risks.

To order Imodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imodium (loperamide) is a peripheral μ‑opioid receptor agonist, whereas alternatives like bismuth subsalicylate act by coating the gut and reducing inflammation. Loperamide typically provides faster reduction of stool frequency, but it must be used with caution in patients with certain cardiac or hepatic conditions.

Imodium should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Imodium is taken orally, usually as a tablet swallowed with water. The tablet should be taken as directed by a healthcare professional or according to the label instructions, and it can be taken with or without food.

Serious risks include severe constipation or ileus, toxic megacolon, allergic reactions such as rash or anaphylaxis, and cardiac arrhythmias like QT prolongation, especially when combined with interacting medications.

Imodium should not be used by individuals with known hypersensitivity to loperamide, children under two years of age, patients with acute dysentery, bacterial enterocolitis, or those with a history of severe constipation or bowel obstruction without medical supervision.